EМА postpones decision on Moderna vaccine until Wednesday

The European Medicines Agency (EMA) has postponed a decision on whether to recommend the use of a second vaccine against Covid-19 until Wednesday, the agency said on Monday evening in Amsterdam, dpa reported.

A committee of EMA experts had met on Monday, two days earlier than initially planned, to discuss the approval of the vaccine developed by US firm Moderna. Some questions remain open, according to the committee's Dutch representative.

The EMA did not rule out the possibility that it might not reach a decision before the committee's scheduled meeting on Wednesday.

The Moderna vaccine has already been approved in the US and Canada.

Once the EMA recommends the vaccine, the European Commission still needs to formally approve it, a step which need not take much time and is seen as a formality.It already green-lighted the use of a vaccine developed by Pfizer and BioNTech in December.

The EU has already ordered 160 million doses of Moderna's vaccine.

More on this subject: Coronavirus

Similar articles

  • Lagarde: ECB to launch climate change centre

    Lagarde: ECB to launch climate change centre

    The European Central Bank is in the process of setting up a climate change centre to coordinate the bank’s thinking on how to best incorporate climate issues into monetary policy and banking supervision, ECB President Christine Lagarde announced today.

  • AstraZeneca cuts vaccine supply to EU by 60% to 31m doses in Q1

    AstraZeneca cuts vaccine supply to EU by 60% to 31m doses in Q1

    Pharmaceutical giant AstraZeneca has cast a major disappointment on EU with intention to supply only 31 million doses of its Covid-19 vaccine in the first quarter of 2021, a senior official familiar with the matter said, quoted by Reuters. The earmarked volumes are short by some 60 percent than previously projected due to production problems.